Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.